India  

Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman

IndiaTimes Friday, 13 June 2025 ()
Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son Aalok will oversee North America as COO. Richard Ascroft will take over as CEO of North America, replacing Abhay Gandhi, as Sun Pharma continues its strategic leadership evolution.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Meet man, set to lead Indian company worth Rs 4 lakh crore as MD after replacing its founder, he is...; business is...

Kirti Ganorkar has been appointed the new managing director of Sun Pharmaceutical Industries -- India's largest pharma firm. Ganorkar, 58, will take charge of...
DNA